ISRCTN14156001
Completed
未知
Feasibility study of an randomised controlled trial to investigate the effectiveness of a humanoid robot to support social skills development in children with an Autism Spectrum Disorder
Hertfordshire Community NHS Trust0 sites40 target enrollmentFebruary 23, 2017
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Specialty: Children, Primary sub-specialty: General Paediatrics
- Sponsor
- Hertfordshire Community NHS Trust
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
2017 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/28645986
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Male and female children aged 5\-10 years
- •2\. Diagnosis of an ASD confirmed by a clinician using ADOS and/or ADI
- •3\. Able to understand or fluently speak English
- •4\. IQ is above 70
Exclusion Criteria
- •1\. Currently in receipt of a privately\-delivered social communication intervention (i.e. not part of NHS or education usual care)
- •2\. The child is non\-English speaking or if non\-verbal, unable to understand English
- •3\. Carer who is completing the questionnaire is unable to do so in English
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Can we do a study to prevent cognitive decline with hearing aids?Cognitive declineMental and Behavioural DisordersISRCTN84550071niversity Medical Center Utrecht24
Completed
Not Applicable
A trial of acceptance and commitment therapy for people with motor neuron diseaseMotor neuron diseaseNervous System DiseasesISRCTN12655391niversity College London Hospitals NHS Foundation Trust206
Completed
Phase 2
Treatment of pain following keyhole surgery in West AfricaPain following laparoscopic cholecystectomySurgeryPost-operative painISRCTN17667918Obafemi Awolowo University69
Completed
Not Applicable
Family focused treatment for Adolescents with Bipolar DisorderISRCTN59769322orthumberland, Tyne and Wear NHS Foundation Trust (UK)36
Completed
Phase 3
Gemcitabine and Docetaxel versus Doxorubicin as first line treatment in previously untreated advanced unresectable or metastatic soft tissue SarcomasISRCTN07742377niversity College London (UCL) (UK)250